Ultrafiltration rate as a dose surrogate in pre-dilution hemofiltration.

Area of Science:

• Nephrology
• Critical Care Medicine
• Biomedical Engineering

Background:

• Continuous hemofiltration (HF) is crucial for critically ill patients.
• Pre-dilution HF allows higher doses but may reduce efficiency compared to post-dilution.
• Understanding the impact of ultrafiltration rate (Qf) on solute removal in pre-dilution HF is essential.

Purpose of the Study:

• To investigate the effect of ultrafiltration rate (Qf) on solute removal parameters in pre-dilution HF.
• To assess clearance and sieving coefficients for small and middle molecules across a range of Qf values.

Main Methods:

• Experiments conducted in an isovolemic, plasma-based pre-dilution system.
• Used a polysulfone hemofilter (1.2 m2) with Qf at 20, 40, and 60 ml/min (Qb=200 ml/min).
• Measured clearance of urea, creatinine, vancomycin, and inulin; also measured sieving coefficients for vancomycin and inulin.

Main Results:

• Solute clearance increased linearly with increasing Qf in pre-dilution HF.
• Sieving coefficients for middle molecules (vancomycin, inulin) were not significantly affected by Qf or time.
• Filter performance is largely maintained even at high Qf values in pre-dilution mode.

Conclusions:

• Pre-dilution HF demonstrates predictable solute clearance that scales with Qf.
• Qf can serve as a reliable surrogate for dosing in pre-dilution HF.
• High Qf values in pre-dilution HF can preserve filter performance for effective solute removal.